Kaneko N, Matsuda R, Hata Y, Shimamoto K. Pharmacological characteristics and clinical applications of K201. Curr Clin Pharmacol. 2009;4(2):126-131. doi:10.2174/157488409788184972

Kaneko N, Matsuda R, Ohtani N, et al. K201 Improves norepinephrine-induced diastolic dysfunction with preserved ejection fraction. Drug Dev Res. 2006;67(11):852-861. doi:10.1002/ddr.20153

Kaneko N, Matsuda R, Toda M, Shimamoto K. Inhibition of annexin V-dependent Ca²⁺ movement in large unilamellar vesicles by K201, a new 1,4-benzothiazepine derivative. Biochim Biophys Acta BBA - Biomembr. 1997;1330(1):1-7. doi:10.1016/S0005-2736(97)00132-6

Kaneko N, Ago H, Matsuda R, Inagaki E, Miyano M. Crystal structure of annexin V with its ligand K-201 as a calcium channel activity inhibitor11Edited by R. Huber. J Mol Biol. 1997;274(1):16-20. doi:10.1006/jmbi.1997.1375

Kaneko N. New 1,4-benzothiazepine derivative, K201, demonstrates cardioprotective effects against sudden cardiac cell death and intracellular calcium blocking action. Drug Dev Res. 1994;33(4):429-438. doi:10.1002/ddr.430330406

Kaneko N, Takeishi M. New Theory on the Pathogenesis of Acute Myocardial Infarction : SYMPOSIUM ON PATHOGENESIS OF MYOCARDIAL INFARCTION : 49th Annual Scientific Session of Japanese Circulation Society. Jpn Circ J. 1986;50(2):198-212. doi:10.1253/jcj.50.198

Endo M, Hirosawa K, Kaneko N, Hase K, Inoue Y, Konno S. Prinzmetal’s Variant Angina. N Engl J Med. 1976;294(5):252-255. doi:10.1056/NEJM197601292940505